The Food and Drug Administration (FDA) has agreed to propose approval and reclassification of cranial electrotherapy stimulation (CES) devices for the treatment of insomnia, depression, and anxiety. In a document to be published tomorrow, the FDA says it is...
FDA to Reclassify CES
read more